The enteric nervous system (ENS) arises from the coordinated migration, expansion and differentiation of vagal and sacral neural crest progenitor cells. During development, vagal neural crest cells enter the foregut and migrate in a rostro-to-caudal direction, colonizing the entire gastrointestinal tract and generating the majority of the ENS. Sacral neural crest contributes to a subset of enteric ganglia in the hindgut, colonizing the colon in a caudal-to-rostral wave. During this process, enteric neural crest-derived progenitors (ENPs) self-renew and begin expressing markers of neural and glial lineages as they populate the intestine. Our earlier work demonstrated that the transcription factor Foxd3 is required early in neural crest-derived progenitors for self-renewal, multipotency and establishment of multiple neural crest-derived cells and structures including the ENS. Here, we describe Foxd3 expression within the fetal and postnatal intestine: Foxd3 was strongly expressed in ENPs as they colonize the gastrointestinal tract and was progressively restricted to enteric glial cells. Using a novel Ednrb-iCre transgene to delete Foxd3 after vagal neural crest cells migrate into the midgut, we demonstrated a late temporal requirement for Foxd3 during ENS development. Lineage labeling of Ednrb-iCre expressing cells in Foxd3 mutant embryos revealed a reduction of ENPs throughout the gut and loss of Ednrb-iCre lineage cells in the distal colon. Although mutant mice were viable, defects in patterning and distribution of ENPs were associated with reduced proliferation and severe reduction of glial cells derived from the Ednrb-iCre lineage. Analyses of ENS-lineage and differentiation in mutant embryos suggested activation of a compensatory population of Foxd3-positive ENPs that did not express the Ednrb-iCre transgene. Our findings highlight the crucial roles played by Foxd3 during ENS development including progenitor proliferation, neural patterning, and glial differentiation and may help delineate distinct molecular programs controlling vagal versus sacral neural crest development.
Introduction
The enteric nervous system (ENS) is a large and complex network of cells that regulates motility, secretion and blood flow in the gastrointestinal (GI) tract. Within the gut muscle wall, interconnected ganglia, consisting of a diverse array of neurons and glia, are organized into the myenteric and submucosal plexi (Gershon, 2010; Gershon et al., 1993) . Cells that form the ENS are derived from neural crest (NC) progenitors that arise from the dorsal neural tube at vagal and sacral levels during early embryonic development (Le Douarin and Kalcheim, 1999) . The vast majority of the ENS is generated from vagal NC cells, which emigrate from the level of somites 1-7 (Le Douarin and Teillet, 1973; Yntema and Hammond, 1954) . In mice, vagal NC cells enter the foregut at~9.0 days post coitum (dpc) and migrate in a rostrocaudal wave along the entire length of the GI tract to generate both neural and glial lineages (Natarajan et al., 1999; Young et al., 1998) . During this process, enteric NCderived progenitors (ENPs) undergo extensive proliferation (Simpson et al., 2007) . In the hindgut, sacral NC, originating posterior to somite 24, contributes a smaller population of ENPs that migrate in a caudorostral direction (Burns et al., 2000; Burns and Le Douarin, 1998) . Sacral NC cells are also responsible for innervation of the urogenital system. During development, sacral NC halts migration after formation of the pelvic ganglia outside the hindgut and does not colonize the distal colon until vagal NC-derived cells are present (~13.5-14.5 dpc) (Druckenbrod and Epstein, 2005; Kapur, 2000) .
Several signaling pathways converge to control cellular functions of multipotent ENPs during ENS development. Members of the GDNF family of ligands signal through Ret and its co-receptor GFRα1 to regulate the migration, proliferation, survival and neural differentiation of ENPs. The effects of GDNF/Ret signaling in ENPs are modulated, in part, by Endothelin 3 signaling mediated by Endothelin Receptor B (Ednrb). Specifically, Ednrb signaling maintains GDNF-driven proliferation (Barlow et al., 2003) , and along with the transcription factor Sox10, inhibits differentiation of enteric neurons (Bondurand et al., 2006; Hearn et al., 1998; Wu et al., 1999) , thus maintaining multipotent enteric neural crest stem cells (NCSCs) in an uncommitted, self-renewing state. Hirschsprung's disease, a congenital disorder characterized by failure of ENPs to completely colonize the gut resulting in absence of enteric ganglia in the colon, is directly linked to defects in NCSC function . Both humans and rodents deficient for several proteins including Sox10, and members of the GDNF and Endothelin 3 signaling pathways, suffer from aganglionosis of the distal colon and the resulting megacolon phenotype (Barlow et al., 2003; Baynash et al., 1994; Enomoto et al., 1998; Hosoda et al., 1994; Schuchardt et al., 1994; Southard-Smith et al., 1998) . Because of the total loss of enteric ganglia in distal intestine of Hirschsprung's disease patients, many ENS studies have focused on this disease, however, other abnormalities of the GI tract, including chronic constipation and functional bowel disorders are likely to be caused by defects that arise during development of the ENS. NCSCs can be isolated from the ENS throughout embryogenesis and into postnatal life, and it is possible that ENS-derived NCSCs may be a source of neurons and glia for regeneration or repair of ENS disorders (Kruger et al., 2002 Metzger et al., 2009) .
During ENS development, multipotent NCSCs co-exist with faterestricted progenitors, but mechanisms coordinating proliferation and lineage specific differentiation of these separate ENP pools are not understood. Markers of neuronal differentiation are readily observed soon after ENPs invade the gut (Baetge and Gershon, 1989) . In contrast, glial lineage markers are first detectable well behind the initial wavefront of migrating ENPs in the fetal mouse gut, indicating that differentiation of glia lags significantly behind differentiation of neurons (Heanue and Pachnis, 2007; Young et al., 2005) . While much is known about molecules required for differentiation of enteric neurons, relatively little is understood about how enteric gliogenesis occurs. An emerging concept is that genes that initially function to maintain multipotency in NCSCs also play additional context-dependent roles in later cell fate decisions. For example, ENPs entering the foregut can be identified by Sox10 or Phox2b expression (Britsch et al., 2001; Corpening et al., 2008; Corpening et al., 2011; Kuhlbrodt et al., 1998; Natarajan et al., 1999; Young et al., 1999) , both of which are individually required for formation and establishment of the ENS (Pattyn et al., 1999; SouthardSmith et al., 1998) . Sox10 maintains multipotency of NCSCs by inhibiting neural cell fates (Kim et al., 2003) and its expression is downregulated in differentiating neurons but maintained in glia (Deal et al., 2006; Kim et al., 2003) . Together with Notch signaling, Sox10 is required for enteric gliogenesis (Okamura and Saga, 2008; Taylor et al., 2007) . Conversely, Phox2b expression levels are decreased in enteric glia (Corpening et al., 2008; Young et al., 1998) and maintained expression of Phox2b is required for developing neurons (Pattyn et al., 1999) .
The forkhead transcription factor Foxd3 is one of the earliest genes expressed in NC progenitors and this expression is maintained as NC cells begin populating the GI tract (Labosky and Kaestner, 1998; Perera et al., 2006; Teng et al., 2008) . Our earlier work demonstrated that a NC-specific deletion of Foxd3 in mice resulted in perinatal lethality and severe defects in most NC derivatives, including complete loss of the ENS Plank et al., 2011; Teng et al., 2008) . Additionally, Foxd3 is required to preserve multipotency of NCSCs and does so by repressing ectomesenchymal differentiation thereby maintaining their ability to generate neurons . Although Foxd3 is required for early NC development, including self-renewal and maintenance of NC multipotency, its expression and cellular functions at later stages of ENS development have not been examined.
Here, we comprehensively mapped Foxd3 expression during murine ENS development and demonstrated that Foxd3 was initially expressed in ENPs and subsequently maintained in differentiated glia. Using a novel Ednrb-iCre transgene, we specifically deleted Foxd3 in a subset of vagal NC-derived ENPs to determine the functions of Foxd3 during late ENS development, after vagal NC cells colonize the proximal GI tract. Our in vivo lineage-mapping experiments demonstrated that Foxd3 functions cell-autonomously to maintain both proliferation and glial differentiation of ENPs. In addition, we discovered a sub-population of Foxd3-expressing ENPs that became activated in response to ENS defects, underwent regulative proliferation and differentiation, and compensated for initial disruption of ENS development due to loss of Foxd3 in vagal NC-derived cells.
Materials and methods

Mouse lines
Foxd3 alleles were described previously (Hanna et al., 2002; Teng et al., 2008 ) were incorporated into the crosses (Soriano, 1999; Srinivas et al., 2001) . In some experiments, the Wnt1-Cre transgenic line (Danielian et al., 1998 ) was used to lineage-map NC. All lines were on a mixed genetic background (CD-1, 129S6, and C57BL/6) and maintained in accordance with protocols approved by the Vanderbilt University Institutional Animal Care and Use Committee (IACUC). DNA for genotyping was extracted from embryonic yolk sac or tail biopsies, and the presence of the Ednrb-iCre transgene was detected by genotyping for iCre with primers (5′-GACAGGCAGGCCTTCTCTGAA-3′) and (5′-CTTCTCCACACCAGCTGTGGA-3′) that amplify a 522 bp fragment. The PCR conditions were 30 cycles of 94°C, 58°C, and 72°C, each for 45 s, followed by 72°C for 10 min. Genotyping for Foxd3 alleles was as described (Hanna et al., 2002; Teng et al., 2008) .
Embryonic dissections and enteric muscle strip preparations
For timed pregnancies, females were checked daily for the presence of a vaginal plug, and noon on the day of plug designated 0.5 days post coitum (dpc). GI tracts (esophagus to anus) were dissected from 10.5 to 16.5 dpc embryos in ice cold PBS, mesentery and other associated organs were removed, and tissue fixed in 4% paraformaldehyde (PFA) in phosphate buffered saline (PBS) for 4 h or overnight and washed in PBS. For muscle strips, the GI tract was dissected from postnatal (P11-P14) or adult mice (2-3 months old) and fixed for 6-8 min in ice-cold neutral buffered formalin. After initial fixation, the intestine was further dissected into three segments corresponding to the duodenum and the proximal and distal halves of the colon. The inner and outer muscle layers, containing the myenteric plexus, were separated from the submucosa of the gut and fixed in 4% PFA for 4 h on ice.
Histology and immunohistochemistry
For wholemount immunohistochemistry, samples were processed as described previously (Corpening et al., 2011) . Briefly, tissues were fixed as described above, permeabilized in 0.5% Triton X-100 at room temperature for 30 min and blocked for 4 h or overnight at 4°C in 10% normal donkey serum, 0.1% Triton X-100 with or without 1% BSA in PBS. After blocking, tissue was incubated in primary antibodies at dilutions given below, washed in PBS with 0.1% Triton X-100, incubated with secondary antibodies and washed, with each step performed overnight at 4°C. For imaging, GI tracts and muscle strips were positioned flat on glass slides and cover-slipped with Aqua PolyMount (PolySciences). For immunohistochemistry on paraffin sections, 10.5 dpc embryos were fixed in 4% PFA in PBS overnight, and processing and histology performed using standard procedures (Presnell and Schreibman, 1997) . The following primary antibodies were used: chicken anti-GFP to detect green fluorescent protein (GFP) from the Foxd3 GFP allele and also for yellow fluorescent protein (YFP) expression from the Cre-recombined and activated R26R YFP allele (used at 1:500, Abcam), rabbit anti-phospho-histone H3 (pH3) (1:200, Upstate Biotechnology), mouse anti-β-III tubulin (TUJ1) (1:500, Covance), mouse anti-glial fibrillary acidic protein (GFAP) (1:500, Sigma), rabbit anti-Foxd3 (1:500, (Tompers et al., 2005) , rabbit anti-fatty acid binding protein 7 (FABP7) (1:500, gift from Dr. Thomas Muller (Young et al., 2003) ), rabbit anti-p75 (1:200, Promega), rabbit anti-protein gene product 9.5 (PGP9.5) (1:1000, AbD Serotec), rabbit anti-S100b (1:500, Dako), and goat anti-Sox10 (1:15 or 1:20, Santa Cruz). Secondary antisera were purchased from Jackson ImmunoResearch: Cy2 donkey anti-chicken (1:500), DyLight TM 488 donkey anti-chicken (1:500), Cy3 donkey anti-mouse (1:700), Cy3 donkey anti-rabbit (1:700), Cy3 donkey anti-goat (1:700), Cy5 donkey anti-mouse (1:500), Cy5 donkey anti-rabbit (1:500), Cy5 donkey antigoat (1:500). 4,6-diamidino-2-phenylindole, dihydrochloride (DAPI, 1:5000, Molecular Probes) was used to detect nuclei. Immunohistochemical experiments were imaged using either an Olympus FV1000 laser scanning confocal microscope or a Zeiss Axio Observer A1 fluorescence microscope and AxioCam MRc5 camera. 5-bromo-4-chloro-3-indolyl-β-D-galactoside (X-gal) reactions (Nagy et al., 2003) and wholemount acetylcholinesterase (AChE) enzyme histochemistry Enomoto et al., 1998) were performed as described and imaged with a Nikon SMZ-U stereomicroscope and Q-Imaging Micropublisher camera. Whole mount preparations were imaged on a Leica MZ 16 FA stereoscope with a QImaging RETIGA 4000R camera.
Quantification of enteric cell types
To quantify enteric cell type specific markers and proliferation in cells with Ednrb-iCre activity, GI tracts from 12.5 dpc-16.5 dpc Ednrb-iCre; R26R
YFP fate-mapped embryos were isolated, subjected to immunofluorescence for YFP, p75, PGP9.5, Foxd3, Sox10 and/or pH3 as indicated, and stained with DAPI as described above. Confocal images of non-overlapping fields were captured with a 40 × objective, corresponding to~0.1 mm 2 per field (x, y) with optical thicknesses (z) ranging from 0.8 to 1.6 μm, with the thickness consistent within each experiment. The z-dimension image from each field that contained the highest number of YFP-expressing cells, and was therefore presumably focused on the myenteric plexus, was digitally analyzed using MetaMorph TM software to determine the total number of YFP, p75, PGP9.5, Foxd3, Sox10, DAPI and/or pH3-positive cells as indicated in individual experiments. Three random fields were quantified in the duodenum and in embryos 14.5 dpc or older, six semi-contiguous fields were also scored in the distal colon from each sample. To determine densities of PGP9.5-expressing cells in colons from control and mutant embryos single confocal z-dimension images from six distinct regions of the colon were thresholded equally and digitally analyzed for area of PGP9.5 and DAPI-positive pixels using ImageJ software (Abramoff et al., 2004) . To quantify enteric glia in adult gut muscle strips, the total number of S100b-positive cells and S100b and YFPexpressing glia were counted in four-five random 20 × fields of the duodenum from three control and five mutant animals and the distal half of the colon from three control and four mutant mice. Images were quantified blindly by two observers using Photoshop software to compare YFP and S100b signals in individual and merged channels and are presented as the average percent of S100b-positive cells that co-expressed YFP. Statistics were calculated as mean ± standard error of the mean (SEM) and significance determined with a two-tailed Student's t-test.
Results
Foxd3 is expressed in ENPs and progressively restricted to glia during ENS development
During early NC development (8.0-10.5 dpc), Foxd3 is initially expressed in all NC cells, but expression is extinguished in cranial and cardiac NC prior to their differentiation into mesenchymal lineages (Labosky and Kaestner, 1998; Mundell and Labosky, 2011; Perera et al., 2006) . Although Foxd3 expression has been reported in the ENS at 10.5-13.5 dpc (Labosky and Kaestner, 1998; Perera et al., 2006; Teng et al., 2008) , expression during ENS development had not been investigated in detail or characterized with cell-type specific markers. Therefore, we examined Foxd3 expression in Wnt1-Cre; R26R
YFP lineage-traced ENPs after their initial colonization of the foregut. At 10.5 dpc, Foxd3 protein expression is detected in the nucleus of YFP-positive cells in the proximal GI tract (Fig. 1A-A″) , consistent with its expression in nearly all ENPs at early stages of ENS development. To circumvent difficulties inherent with antibodies generated from the same species and to label Foxd3-expressing cells throughout the cytoplasm, we examined immunohistochemical colocalization of Foxd3 with GFP from the Foxd3 GFP allele using celltype specific markers, an approach used previously (Perera et al., 2006) . To confirm that GFP from the Foxd3 GFP allele accurately represented endogenous Foxd3 expression, we examined GFP and Foxd3 protein expression during late ENS development in 16.5 dpc Foxd3 GFP embryos and in gut muscle strips from postnatal day 14 (P14) Foxd3 GFP mice. At both stages, Foxd3 protein was co-expressed in the nuclei of GFP-positive cells throughout the ENS in the majority of cells , indicating that Foxd3 was expressed in ENPs during and after enteric neuron and glial lineage segregation. We detected very few GFP-positive cells that lacked staining for Foxd3 protein ( Fig. 1B -B″, green arrows), which may result from the perdurance of GFP or examination of focal planes lacking a nucleus.
To establish the identity of Foxd3-expressing cells within enteric ganglia we performed immunohistochemical co-localization of GFP with markers for undifferentiated NC cells, neurons and glia. Consistent with a role for Foxd3 in enteric neural/glial progenitors, at 16.5 dpc, GFP expression largely overlapped with expression of the low-affinity nerve growth factor receptor (p75), a NC progenitor and ENP marker ( Fig. 2A-A″) . In addition to GFP/p75 doublepositive cells, we detected a small population of GFP-positive cells that did not express p75 (green arrows), suggesting that these cells may have initiated differentiation ( Fig. 2A) . To assess the differentiation status of Foxd3-expressing cells, we examined GFP expression together with expression of the neural marker PGP9.5. At 16.5 dpc, most Foxd3-expressing cells were located adjacent to neurons and very few GFP-positive cells co-expressed PGP9.5 (yellow arrow in The smaller stellate morphology and location of Foxd3-expressing cells closely juxtaposed to enteric neurons strongly suggested that these cells were enteric glia. To address this possibility, we performed co-immunodetection of the glial cell markers Sox10 and S100b with GFP from the Foxd3 GFP allele at embryonic and postnatal stages. At 16.5 dpc, nearly all NCSCs and glia, marked by Sox10, were co-labeled with GFP ( Fig. 2D ), demonstrating that Foxd3 is maintained in ENPs and glia. By P14, co-localization of GFP and Sox10 indicated that Foxd3 expression is maintained in mature enteric glial cells (Fig. 2E ). Further immunofluorescent co-labeling of GFP and the mature glial marker S100b also showed almost complete overlap with GFP expression from the Foxd3 GFP allele at 16.5 dpc and P14 ( Together, these expression patterns demonstrated that Foxd3 was broadly expressed in ENPs, progressively downregulated as cells underwent neuronal differentiation, and maintained in differentiated glia.
Spatiotemporal characterization of Ednrb-iCre activity
Previous tissue-specific deletion of Foxd3 within early, and presumably uncommitted, NC progenitors with Wnt1-Cre or Pax3
Cre resulted in a complete loss of the ENS Nelms et al., 2011; Plank et al., 2011; Teng et al., 2008) . However, it is not known whether Foxd3 is required later in the sublineage of NC cells that generate enteric neurons and/or glia. To conditionally delete Foxd3 after specification of ENPs and initial migration of vagal NC cells into the GI tract, we generated a transgenic mouse line, Ednrb-iCre, in which expression of Cre-recombinase is directed by an ENS-specific enhancer of Ednrb (Fig. 3A) . This Ednrb enhancer was characterized previously and consists of a genomic fragment (−1.2 kb to −160 bp) upstream of the Ednrb start site (Zhu et al., 2004) . This~1 kb enhancer in combination with a minimal promoter is sufficient to direct expression to ENPs after they colonize the foregut and small intestine. To generate these transgenic mice, the enhancer element was linked to an Hspa1b (Hsp68) minimal promoter to direct expression of a codon-improved Cre recombinase (iCre) (Shimshek et al., 2002) . The tissue specificity of Cre activity from this transgene was verified by breeding Ednrb-iCre mice with R26R lacZ or R26R YFP reporter mice in which Cre expression results in excision of a stop codon and expression of lacZ or YFP. In wholemount analysis of Ednrb-iCre; R26R lacZ embryos, X-gal staining was faintly detected in the developing GI tract when ENPs are approaching the cecum at 11.0 dpc (40-42 somite stages), but was not detected in embryos 10.5 dpc or younger ( Fig. 3B-C′) . Later, at 11.5 dpc, Cre activity was detected in ENPs populating the GI tract from the esophagus to the cecum (Fig. 3D-E′) . Cre activity was also detected within the neural tube ( Fig. 3F -G) as expected (Lee et al., 2003; Zhu et al., 2004) ; however, activity within the NC was limited to ENPs within the GI tract and was not detected in other NC derivatives including NC in the outflow tract of the heart, skin, cranial ganglia or dorsal root ganglia (DRG) (Fig. 3C -G and data not shown).
Ednrb-iCre activity is specific to vagal NC-derived cells
To determine if Foxd3 is expressed in cells with Ednrb-iCre mediated Cre activity, we evaluated Foxd3 protein expression in the duodenum versus colon from Ednrb-iCre; R26R
YFP lineage-traced embryos. At 15.5 dpc, the vast majority of Foxd3-expressing cells in the duodenum showed Ednrb-iCre-activated YFP expression (Fig. 4A) indicating Cre activity in ENPs and differentiating glia. This pattern was identical to previously reported co-expression of this enhancer with Sox10 in vagal NCderived progenitor cells (Zhu et al., 2004) . Examination of Foxd3 and YFP expression at higher magnification revealed that a small fraction of Foxd3-expressing cells did not exhibit Cre activity (red arrow, Fig. 4A′ ), suggesting that a small sub-population of Foxd3-expressing ENPs did not activate the Ednrb enhancer. At this stage, sacral NCderived ENPs are present in the distal colon and in the adjacent pelvic ganglia. Ednrb is expressed in sacral NC (Delalande et al., 2008) , however, it was unknown whether the 1 kb enhancer region drives expression To address the question of whether the transgene was expressed in all p75-expressing ENPs, we again used wholemount immunofluorescence in lineage mapped embryos and showed that the Cre-activated YFP from the R26R YFP allele was co-localized with p75 in the majority of ENPs at 12.5 dpc and at 15.5 dpc (yellow arrows in Fig. 4C, D) . Quantification of these data revealed that in 12.5 dpc embryos, the majority of p75-expressing cells also expressed YFP (~95%, red arrow, Fig. 4C , quantification in Fig. 4E ) and this population decreased to approximately 80-82% at 15.5 dpc (Fig. 4D, E) . We used the same approach to determine whether the Ednrb-iCre lineage included enteric neurons using immunohistochemistry for YFP together with PGP9.5 at 12.5 dpc and 15.5 dpc (Fig. 4F, G) . These data showed that the lineage-mapped neural population does not overlap as completely compared to the p75 population; approximately 53-62% of PGP9.5-positive enteric neurons are labeled by this transgene at both stages. These data are quantified in Fig. 4H . The decreased overlap of Foxd3 and YFP expression observed in the colon versus the duodenum (Fig. 4) suggests two non-exclusive possibilities: 1) that Ednrb-iCre activity is specific to vagal ENPs and is not present in sacral ENPs, or 2), that a significant number of Foxd3-expressing cells do not express Cre and/or have delayed activation of the transgene. To determine if Cre activity was present in sacral NC derivatives, we examined expression of p75 in the sacral NC-derived pelvic plexus and compared this to activation of the R26R YFP reporter with the NC-specific Wnt1-Cre transgene versus Ednrb-iCre. At 14.5 dpc, Yellow arrows indicate cells that co-expressed GFP and Sox10. 16.5 dpc GI tracts from Foxd3 GFP embryos (F) and gut muscle strips from Foxd3 GFP postnatal day 14 mice (G) processed with antibodies against GFP (green) and S100b (red) confirmed Foxd3 expression in glial cells during specification of enteric lineages. Examples of cells that co-expressed GFP and S100b are indicated with yellow arrows. Red arrows indicate S100b-positive cells that lacked GFP expression and green arrows indicate cells that expressed GFP but not S100b. Images were captured with a 40× oil objective. Scale bars= 100 μm.
Wnt1-Cre fate-mapped YFP-expressing sacral NC-derived cells were present within pelvic ganglia as marked by p75 (pelvic ganglion indicated by arrows, Fig. 5A-A′) . In stark contrast, Ednrb-iCre mediated expression of YFP was not detected in pelvic ganglia at 14.5 dpc or 16.5 dpc (Fig. 5B-E′) , although YFP-expressing cells are detected within the colon in the same samples. These data suggest that Ednrb-iCre expression is limited to vagal NC-derived ENPs, and highlight the utility of this Cre transgene to label and distinguish vagal ENPs versus those derived from the sacral NC.
Effect of deleting Foxd3 in ENPs using Ednrb-iCre
Foxd3 is required for NC colonization of the GI tract and establishment of all ENPs (Teng et al., 2008) , but its role in later ENS development had not been explored. To selectively delete Foxd3 within the vagal NC-derived ENS, we mated ; Ednrb-iCre (mutant) mice (matings diagrammed in Fig. 6 ). Embryos and mice were found in expected ratios for each genotype at all stages during development and as adults, suggesting that no lethality was caused by loss of Foxd3 in the Ednrb-iCre lineage. Litters were monitored for general health and appearance and GI tracts dissected to determine whether these mice suffered from megacolon phenotypes. However, Foxd3 mutant mice survived well into adulthood with overtly normal morphology of the entire GI tract. There were no differences in weight of control and mutant littermates (data not shown) suggesting little or no defects in nutrition, overall growth and general health of mutant mice.
To determine if enteric neurons were disrupted in postnatal (P11) or adult (6 week old) mice we performed wholemount analysis of enteric neurons labeled by acetylcholinesterase (AChE) activity. As expected from the health of the animals, neurons were present in enteric ganglia throughout the GI tracts from control and mutant mice although the patterning of duodenal ganglia appeared slightly irregular with greater spaces between ganglia (Fig. 7A, B) . To better understand this result and verify that Foxd3 was absent in Cre-expressing cells, we used wholemount immunodetection of Foxd3 and YFP in isolated GI tracts from 16.5 dpc embryos carrying the R26R YFP reporter allele. In control embryos, the majority of Foxd3-expressing cells in both the duodenum and colon showed co-labeling with Foxd3 and YFP (yellow arrows, Fig. 7C,  D) , though a population of Foxd3-expressing cells did not show Cre activity (red arrows, Fig. 7C, D) . In contrast, in Foxd3 mutant embryos, we detected a large number of Foxd3-positive ENS cells that did not express Cre (red arrows in Fig. 7C-D) . Despite the reduced number of YFPexpressing cells in GI tracts from mutant embryos, the overall number of Foxd3-expressing cells was similar between control and mutants in both the duodenum and colon ( Fig. 7C, D ; individual channels shown in Fig. S4 ; data quantified in Fig. 7E-F) . The large number of Foxd3-expressing cells in mutants was not due to a failure of Cre to delete Foxd3 in the Ednrb-iCre lineage; Foxd3 expression was not detected in YFP-expressing cells in the duodenum and only a few cells showed co-labeling in the colon (yellow arrow, Fig. 7D ), indicating efficient deletion of the Foxd3 flox allele by Ednrb-iCre. These curious results suggested a cell-autonomous role for Foxd3 during ENS development (as indicated by reduced numbers of YFP-positive cells) but also implied that a sub-population of Foxd3-expresssing ENPs that does not express Ednrb-iCre may expand and compensate for the apparent reduction in Ednrb-iCre lineage cells.
Foxd3 is required to maintain ENPs during development
Although our initial analysis of Foxd3 mutant mice suggested that they had an overtly functional ENS, slight patterning irregularities observed in enteric ganglia (Fig. 7A-B) and the prominent role of Foxd3 in early NC development prompted us to focus our analysis on earlier developmental stages. To determine if Foxd3 is required for proper migration, distribution, and patterning of vagal NC-derived ENPs, we evaluated GI tracts from control and mutant embryos with Ednrb-iCre activated R26R lacZ and X-gal staining from 11.5 dpc to 15.5 dpc. After initial expression of Cre at 11.5 dpc in Foxd3 flox/+ ; Ednrb-iCre (control) embryos, many X-gal-positive cells were detected on the surface of the proximal GI tract up to the level of the cecum-hindgut boundary, consistent with their identity as ENPs (Fig. 8A, inset) . In Foxd3 flox/− ; Ednrb-iCre (mutant) embryos at 11.5 dpc, X-gal staining was initially modestly reduced and X-galpositive cells were detected at caudal levels in the cecum similar to controls (Fig. 8B) . In contrast, direct comparison of X-gal labeling in Foxd3 mutant and littermate controls at 13.5 dpc demonstrated a pronounced decrease in the density of ENPs in the GI tract from mutant embryos compared to controls (Fig. 8C, D) . Control vagal NCderived ENPs had migrated through the proximal half of the hindgut at 13.5 dpc (Fig. 8C) . Despite their decreased numbers, Foxd3 mutant cells migrated to a comparable level in the colon (Fig. 8C, D) . By 15.5 dpc, when control vagal NC cells had completed colonization of the GI tract to the distal end of the colon (Fig. 8E, E′) , the number of mutant X-gal labeled cells was severely reduced throughout the gut (Fig. 8F ) and no Xgal-positive cells were detected in the distal colon from 15.5 to 16.5 dpc embryos (arrow in Fig. 8F′ and data not shown). Using the R26R YFP reporter allele to facilitate visualization of sparse Cre-expressing cells, we again detected decreased numbers of mutant YFP-positive cells in the distal tip of the colon at 16.5 dpc (Fig. 8G-H) . These data demonstrated a progressive reduction of (red) in ENPs at 12.5 dpc (C) and at 15.5 dpc (D). Yellow arrows in C and D indicate the majority population of ENPs that co-expressed YFP and p75. A small population (~5%) of p75 + cells did not show Ednrb-iCre activity in GI tracts from 12.5 dpc embryos (red arrows, C, D) and this population increased in number to~18-20% at 15.5 dpc (quantified in E). (F-H) Immunohistochemistry for YFP and the neural marker PGP9.5 (red) at 12.5 dpc (F) and 15.5 dpc indicated that Ednrb-iCre activity labels enteric neurons at both early and late stages of ENS development. Quantification of PGP9.5-expressing cells is shown in H. Data in E and H represent p75 or PGP9.5-positive cells imaged with a 40 × oil objective and counted in random fields of duodena from 12.5 dpc embryos or duodena and colons from 15.5 dpc embryos (n = 3 for each). All statistics are mean ± SEM, *(p b 0.05).
ENPs in mutant embryos that was more severe at caudal levels of the GI tract, and suggested a role for Foxd3 in maintaining vagal NCderived ENPs during ENS development.
Patterning and distribution, but not differentiation, of enteric neurons is disrupted in Foxd3 mutant ENS
Our previous work demonstrated that Foxd3 preserves neural potency of early NC cells . However, it was unknown whether Foxd3 maintains neural potency after cells are specified as ENPs. The decrease in the number of Foxd3 mutant cells within the GI tract of Foxd3 flox/− ; Ednrb-iCre embryos may indicate a similar role for Foxd3 in maintenance of neural fate of ENPs. Wholemount immunohistochemistry with subsequent confocal analysis of GI tracts from control embryos revealed a dense meshwork of tightly packed PGP9.5-positive neurons present in the duodenum (Fig. 9A) . PGP9.5-expressing cells showed extensive but not complete overlap with YFP expression, suggesting that the majority of vagal NC-derived enteric neurons arise from Ednrb-iCre-expressing cells (Fig. 9A) . In stark contrast, reduced numbers of YFP-expressing cells in duodena from Foxd3 mutant embryos was associated with alterations in the density and distribution of enteric neurons (Fig. 9A) . Similar results were seen in colons from control and mutant embryos (Fig. 9A) . Interestingly, despite a 48% reduction of YFP-positive cells in the duodenum and a 72% reduction in the colon (Fig. 9B) , the majority of mutant YFP-positive cells showed colabeling with PGP9.5, suggesting that neuronal differentiation was not overtly impaired by loss of Foxd3. This is perhaps not surprising, considering the restriction of Foxd3 expression from differentiating neurons in control GI tracts described above (Fig. 2) , although these results support a different role for Foxd3 in ENPs versus early multipotent NC. To examine the density of neurons along the length of the colon we used immunodetection of PGP9.5 in sequential non-overlapping fields of colons from control and mutant embryos at 15.5 dpc (Fig. 9C) . Quantification of these data clearly showed that the density of neurons was slightly decreased the whole length of the colon, but this difference was statistically significant only at the most distal end (Fig. 9D) . Therefore, while Foxd3 was not absolutely required for neural differentiation, the number of ENS-neurons was greatly reduced in Foxd3 mutant ENS.
ENPs require Foxd3 for proper glial cell differentiation and/or maintenance
Our data demonstrated that Foxd3 was initially expressed in ENPs and that expression was selectively maintained in differentiated glia during late ENS development, suggesting lineage-specific roles for Foxd3. As shown above, differentiation of neurons was not overtly impaired in mutant GI tracts. To investigate differentiation of glial lineages, we examined expression of glial markers (S100b and Sox10) in Foxd3 mutant embryos and mice. At 16.5 dpc, analysis of S100b expression in the duodena of lineage-traced embryos revealed that, in contrast to control embryos ( Fig. 10A-A″) , there were reduced numbers of enteric glia from the Ednrb-iCre lineage in mutant guts ( Fig. 10B-B″) . At this stage, glial differentiation is not complete in the distal GI tract, therefore further analysis of glial differentiation Fig. 6 . Breeding strategy to generate mice with an ENS-specific deletion of Foxd3. Fate mapping was performed using either the R26R YFP allele or R26R lacZ allele to label EdnrbiCre lineage cells in control and mutant embryos and mice. in the colon was completed in adult ENS. Co-labeling of Sox10 with YFP in gut muscle preparations from the duodena and distal colons of adult (2-3 months old) control and mutant mice showed that, the number of Sox10/YFP double-positive cells was reduced in both duodena (Fig. 10C, D) and colons (data not shown) from mutant mice compared to controls. Quantification of enteric glia (labeled by S100b expression) and YFP-expressing cells in the duodenum and colon confirmed severely reduced numbers of differentiated glia in mutant Ednrb-iCre lineage cells compared to controls (Fig. 10E-H ): S100b/YFP double-positive cells were reduced by 78% in duodenum (Fig. 10G ) and 84% in the colon (Fig. 10H ). Despite these greatly reduced numbers of glia from the Ednrb-iCre lineage in mutants, the overall numbers of Sox10 or S100b-positive glia were similar to controls (Fig. 10C-F) , and Sox10-positive glia were present in the distal end of the colon (Fig. 9C) , consistent with our hypothesis that an independent population of ENPs compensated for the loss of the Ednrb-iCreexpressing cells.
Foxd3 is required cell autonomously for proliferation of ENPs
During colonization of the GI tract, vagal ENPs proliferate in order to generate the progenitor pool needed to complete population of the entire the gut (Simpson et al., 2007) . The severe reduction of Ednrb-iCre lineage cells we observed in mutant embryos may reflect a requirement for Foxd3 in proliferation and/or survival of ENPs. To investigate the possibility that Foxd3 is required for proliferation and expansion of the ENP pool, we monitored proliferation in the duodena and colons from R26R YFP fate-mapped control and mutant embryos using immunohistochemistry for phospho-histone H3 (pH3), to label cells undergoing mitosis (Fig. 11A, D) . In confocal images through the developing enteric plexus, all YFP-positive cells were scored as either pH3-positive or -negative and proliferation of ENPs was calculated as the percent of Ednrb-iCre lineage cells (YFP+) that were also pH3-positive.
Additionally, to compare proliferation of the entire ENP pool with proliferation of Ednrb-iCre lineage cells, we quantified the number of cells positive for both pH3 and the ENP marker Sox10 (Fig. 11A , C, D, F) in both duodena and colons (magenta arrows in Fig. 11A, D) . At 14.5 dpc, proliferation of mutant YFP-positive cells in the duodena and colon was significantly reduced compared to control embryos (Fig. 11A, B, D, E) . However, the overall proliferation of Sox10-expressing ENPs was unchanged in both the duodena and colons (quantified in Fig. 11C, F) . This suggests that in mutants, ENPs outside the Ednrb-iCre lineage compensate for the loss of Foxd3 in the Ednrb-iCre lineage by increasing proliferation compared to control embryos. These results support the hypothesis that a sub-population of the ENS undergoes expansion to compensate for the loss of Cre-expressing Foxd3 mutant cells. Further analysis was done to examine apoptosis in GI tracts from fate-mapped control and mutant embryos, and these experiments showed no difference between controls and mutants (data not shown), suggesting that loss of Foxd3 did not affect survival of ENPs. Together, our data demonstrate that Foxd3 is required to maintain proliferation of vagal NC-derived ENPs throughout the GI tract and suggests that deletion of Foxd3 in a subset of the ENS resulted in the compensatory proliferation of non-Ednrb-iCre ENS cells.
Discussion
Foxd3 is required at multiple stages of ENS development
During migration, ENPs undergo self-renewing divisions to maintain both neural and glial potency and generate a progenitor pool sufficient to form the entire ENS (Natarajan et al., 1999) . Our previous work demonstrated that Foxd3 is essential in early NC progenitors for multipotency, self-renewal and generation of NC cells competent to enter the GI tract Teng et al., 2008) . However, the role of Foxd3 in later ENS development had not been F) demonstrated that the density of Foxd3 mutant Cre-expressing cells was progressively reduced along the proximal-distal extent of the GI tract from 11.5 to 15.5 dpc. At 11.5 dpc, control ENPs populated the GI tract to the level of the cecum (A, inset arrow), and were located in the proximal colon at 13.5 dpc (C, arrow indicates caudal-most cells). At both 11.5 and 13.5 dpc, fewer Foxd3 mutant Ednrb-iCre lineage cells migrated to a similar caudal level in the GI tract compared to control embryos (arrows in inset for A, B, arrows in C, D). In control embryos, X-gal-positive cells colonized the distal colon at 15.5 dpc (E, E′). Foxd3 mutant ENPs were reduced in number throughout the GI tract and were not detected in the distal colon (F, F′). Arrows in E′ and F′ indicate caudal extent of X-gal-positive cell colonization in the distal colon. (G) Immunodetection of YFP from the recombined R26R YFP allele in control (G-G′) and mutant (H-H′) embryos showed that Ednrb-iCre expressing cells were reduced in number throughout colons from 16.5 dpc mutant embryos, but were present at the distal colon. Abbreviations: duo, duodenum; eso, esophagus.
examined. Here, we present data demonstrating that Foxd3 expression is maintained in both ENPs and glia and that Foxd3 plays a critical role in ENPs and glia throughout development of the ENS. Further, we identify a subpopulation of Foxd3-expressing ENPs that undergo regulative proliferation and differentiation to compensate for loss of a large portion of the ENPs that express Ednrb-iCre.
Activity of Ednrb-iCre is specific for vagal NC cells
We generated and characterized an ENS-specific transgenic Cre line that labels vagal, but not sacral-derived, ENPs. Ednrb-iCre activity is first detected in vagal-derived NC cells at 11.0 dpc as ENPs migrate through the midgut and cecum. Using molecular markers in combination with fate mapping of the Ednrb-iCre lineage, we demonstrated that this novel Ednrb-iCre transgene labels the majority of Foxd3-expressing cells within vagal-derived ENPs and the Ednrb-iCre lineage cells generate both neurons and glia during ENS development. Our finding that Ednrb-iCre expression specifically labels vagal, but not sacral NC, suggests that this novel Cre transgene could be useful for identification of molecular differences between vagal and sacral NC cells during development. Previous studies suggested that vagal and sacral NC have intrinsic differences in their ability to generate the ENS (Burns et al., 2002; Burns and Le Douarin, 1998) . However, there is considerable controversy about the relative role of sacral versus vagal NC, primarily due to lack of specific molecular markers for each population. Gene profiling of vagal versus sacral NC from neural tube explant cultures failed to identify genes specifically expressed in either NC population (Delalande et al., 2008) , suggesting that identification of migratory vagal and sacral ENPs in situ may be required to definitively profile their gene expression and in vivo characteristics. Although there are a few molecular markers limited in their expression to the vagal NC, including a Hoxb3 enhancer, which is expressed in a sub-population of vagal NC-derived neurons but absent from enteric glial lineages (Chan et al., 2005; Lui et al., 2008) , a specific and all-encompassing marker of vagal NC cells remains elusive. Currently, the relative extent of sacral NC contribution to the distal GI tract in mammals as well as intrinsic molecular differences between these two NC populations is unknown. Our data suggest that lineage labeling of Ednrb-iCre expressing cells would allow for prospective isolation and gene profiling of the overwhelming majority of vagal NC-derived cells from the GI tract, potentially resolving some of these unanswered questions.
Maintenance of proliferation and gliogenesis during ENS development
Foxd3 is broadly expressed as ENPs enter the gut and then downregulated as they undergo progressive differentiation to neuronal fates. In contrast, Foxd3 was maintained in p75-expressing ENPs and S100b-positive glia well after initial ENP colonization of the GI tract. Our data demonstrating that Foxd3 is required to maintain proliferation and glial differentiation, but not neuronal differentiation, are consistent with the temporal expression of Foxd3. This is also consistent with the possibility that downregulation of Foxd3 in ENPs may be an important step in specification of enteric neurons. This is in contrast to recent data showing that the transcription factor Hand2 functions primarily in neurogenesis (Lei and Howard, 2011) , implying molecularly distinct programs of differentiation for these two co-dependent lineages. At present, the transcription factors and signaling pathways that regulate the dynamic expression of Foxd3 during ENS development are unknown and the molecular pathways in which Foxd3 functions to maintain both ENPs and enteric glia have not yet been identified.
Examination of the spatiotemporal expression pattern of Foxd3 revealed that it is comparable to Sox10 expression during ENS development (Kuhlbrodt et al., 1998) . Here we showed that Foxd3 is required to maintain Sox10-expressing glia within the Ednrb-iCre lineage, consistent with our previous work in other regions of the NC Teng et al., 2008) . Because Sox10 is essential for the maintenance of ENPs (Paratore et al., 2002; Southard-Smith et al., 1998) , and for differentiation and maturation of peripheral nervous system glia (Britsch et al., 2001; Finzsch et al., 2010) , it is possible that the combined defects in maintenance of ENPs and specification of enteric glia observed in Foxd3 flox/− ; EdnrbiCre embryos may be related to loss or reduction of Sox10. At present there is no genetic evidence of a functional interaction between Foxd3 and Sox10, although bioinformatic analysis identified putative Foxd3 binding sites in the first intron of the zebrafish sox10 gene, (Dutton et al., 2008 ) and more recent work described a different Foxd3 binding site upstream of Sox10 and a synergistic mechanism between Foxd3 and Sox2 proteins in the control of Sox10 transcription in murine NC-derived neuroblastoma cell lines (Wahlbuhl et al., 2011) . Further investigation of the precise pathways and mechanisms through which Foxd3 maintains ENS proliferation and gliogenesis will provide a more complete understanding of the transcriptional regulation mediating ENS development.
Compensation in Foxd3 mutant ENS
A surprising finding from our work is that deletion of Foxd3 in the Ednrb-iCre lineage does not disturb the overt function of the ENS; the mutant mice appear healthy and we detected no changes in weight or lifespan. Despite initial disruption of neural patterning at embryonic stages, AChE histochemistry revealed only modest alterations in connectivity of postnatal enteric ganglia, and lethality or obstructive bowel disease was not evident in postnatal or adult mutant mice. Our lineage-mapping data demonstrate that normally, ENPs within the Ednrb-iCre lineage contribute the majority of neurons and glia within the developing ENS. In fact, a deletion of the endogenous Ednrb ENS-specific enhancer used to generate the Ednrb-iCre transgene resulted in loss of ENPs in the cecum and hindgut and postnatal death from megacolon (Zhu et al., 2004) . This clearly demonstrates that the ENPs activating this enhancer are critical for late stages of ENS development. In contrast, in Foxd3 mutants, we describe a profound shift in the relative contribution of enteric sub-lineages such that the ENS was primarily formed from non-Ednrb-iCre lineage cells. Our results are consistent with the possibility that an independent population of ENPs expands in number following deletion of Foxd3 within the Ednrb-iCre lineage. Concomitant with decreased proliferation in mutant Ednrb-iCre-expressing cells, overall proliferation in the ENP pool was unchanged compared to controls. We interpret these data to conclude that a unique sub-population of Foxd3 and Sox10-expressing ENPs that did not express the Ednrb-iCre transgene underwent activation, regulative proliferation and differentiation into both neuronal and glial lineages in response to the severe depletion of Ednrb-iCre lineage cells.
Regulative lineage compensation, in which an independent cell population functionally compensates for loss of another, may be a common mechanism for overcoming developmental deficiencies. However, few studies have defined mammalian cell populations with this potential. During skeletal muscle development in mice, conditional ablation of Myf5-expressing cells results in lineage compensation by a Myf5-independent cell population that prevents disruption of myogenesis (Haldar et al., 2008) . In the zebrafish NC, regulative lineage compensation has been suggested for genetically distinct populations of NC-derived melanophore precursors; depletion of erbb3b-dependent nerve-associated melanophore precursors resulted in increased proliferation and differentiation of remaining melanophore progenitors (Budi et al., 2011) . This is not the first description of compensation within the ENS; a deletion of Hand2 in the Nestin-expressing ENPs resulted in compensation from ENPs that did not express the Nestin-Cre transgene used in that study (Lei and Howard, 2011) . In addition, the compensatory changes we observe here are similar to those observed in chimeric mice showing that a lack of Ednrb in a sub population of ENPs could be overcome by wild type ENPs in the duodenum but not in the distal colon (Kapur et al., 1995) . An alternative possibility is that the Ednrb-iCre lineage may represent a more restricted transient-amplifying ENP population able to generate some neural and glial cells, but distinct from multipotent NCSCs present during initial colonization of the GI tract. While our data suggest the ENS in Foxd3 flox/− ; Ednrb-iCre mice contained neurons and glia that were quantitatively comparable to control mice, we cannot rule out the possibility that some enteric cell types were differently affected by the loss of Foxd3. Our data demonstrating increased non-Ednrb-iCre lineage proliferation and gliogenesis in both the duodenum and colon of Foxd3 mutant embryos suggests that sacral NC may not compensate for loss of Ednrb-iCre lineage cells in all regions of the GI tract. However, given that Foxd3 was deleted after vagal NC colonization of the proximal GI tract, . Quantification of the proliferating Ednrb-iCre lineage cells (E) and the proliferation of Sox10-positive cells (F) in colons from 14.5 dpc control and mutant embryos again showed a decrease in proliferation in YFP-positive Foxd3 mutant ENPs and a subsequent increase in Sox10-expressing cells that did not co-express YFP. Data represent confocal analysis of GI tracts from 3 mutant and 3 littermate control embryos. 9 non-overlapping 40× confocal images (3 fields from duodena and 6 fields from colons) were analyzed from each embryo. *(p b 0.05). Scale bars= 50 μm. All statistics are mean ± SEM, *(p b 0.05).
another possibility is that the sacral NC ENP pool was activated to form an increased proportion of the distal ENS.
Implications for regenerative medicine
NCSC replacement has been suggested as a cell-based therapy for Hirschsprung's disease and other GI neurodegenerative diseases (Bondurand et al., 2003; Kruger et al., 2002; Micci and Pasricha, 2007) . However, therapeutic use of NCSCs for regeneration of the ENS will require a better understanding of the dynamic cellular properties of ENPs and the distinct sub-populations of ENPs that generate the ENS during development. Recent data showed that adult gutderived NCSCs, while they have the capacity to generate both neurons and glia in vitro, give rise predominantly to glia in physiological settings, thereby suggesting that ENS neurogenesis from autologous sources may be challenging (Joseph et al., 2011) . The ability to activate intrinsic enteric NCSC populations to induce repair of congenital bowel defects is an intriguing possibility. However, before that possibility can be realized, it will be important to identify genes and signaling pathways controlling the self-renewal, migration and differentiation of ENPs in vivo. Our findings demonstrate several crucial roles played by Foxd3 during ENS development including maintenance of the ENP pool, neural patterning and glial differentiation. In addition, our results suggest that distinct sub-lineages of ENPs are intrinsically able to respond to ENS injury or disease.
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